文献速递造血干细胞移植与细胞治疗

微生物来源的短链脂肪酸丁酸和丙酸与慢性GVHD的保护相关

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
PubMed 文献 · Blood · 2020-01-01

该研究采用病例对照设计分析allo-HCT后晚期粪便和血浆样本,发现发生cGVHD患者在100天血浆中微生物来源短链脂肪酸丙酸和丁酸浓度低于未发生者,并在独立移植中心的横断面队列中重现,但第三中心血清样本未重现该差异,提示肠道微生物可能通过调控系统性短链脂肪酸浓度发挥免疫调节作用。

要点

  • 初始病例对照队列中,发生cGVHD患者第100天血浆丙酸和丁酸浓度低于未发生cGVHD者。
  • 来自独立移植中心的横断面队列重现了血浆中丙酸和丁酸与cGVHD的负相关。
  • 第三移植中心血清样本未重现血浆中观察到的短链脂肪酸差异。

核心结论

  • 来自初始病例对照队列和2个横断面队列中1个的结果提示,肠道微生物群可能至少部分通过控制微生物来源短链脂肪酸的系统性浓度,在allo-HCT患者中发挥免疫调节作用。

研究设计与样本

  • 研究采用病例对照设计,分析allo-HCT后晚期采集的粪便和血浆样本。
  • 初始病例对照队列来自移植患者,另有两个来自独立移植中心的横断面队列。

主要发现

  • 在初始病例对照队列中,发生cGVHD患者第100天血浆丙酸和丁酸浓度低于未发生该并发症者。
  • 在来自独立移植中心的进一步横断面队列中,同样观察到发生cGVHD患者血浆丙酸和丁酸浓度较低。
  • 来自第三移植中心的横断面队列仅有血清(而非血浆)样本,未重现血浆样本中观察到的短链脂肪酸差异。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 来自第三移植中心的横断面队列仅有血清而非血浆样本,未重现血浆中观察到的短链脂肪酸差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Studies of the relationship between the gastrointestinal microbiota and outcomes in allogeneic hematopoietic stem cell transplantation (allo-HCT) have thus far largely focused on early complications, predominantly infection and acute graft-versus-host disease (GVHD). We examined the potential relationship of the microbiome with chronic GVHD (cGVHD) by analyzing stool and plasma samples collected late after allo-HCT using a case-control study design. We found lower circulating concentrations of the microbe-derived short-chain fatty acids (SCFAs) propionate and butyrate in day 100 plasma samples from patients who developed cGVHD, compared with those who remained free of this complication, in the initial case-control cohort of transplant patients and in a further cross-sectional cohort from an independent transplant center. An additional cross-sectional patient cohort from a third transplant center was analyzed; however, serum (rather than plasma) was available, and the differences in SCFAs observed in the plasma samples were not recapitulated. In sum, our findings from the primary case-control cohort and 1 of 2 cross-sectional cohorts explored suggest that the gastrointestinal microbiome may exert immunomodulatory effects in allo-HCT patients at least in part due to control of systemic concentrations of microbe-derived SCFAs.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Markey KA, Schluter J, Gomes ALC, et al. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood. 2020. PMID: 32430495. doi:10.1182/blood.2019003369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。